Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ:MIRA
MIRA Pharmaceuticals, Inc. (MIRA) Stock Price & Analysis
34 Followers
MIRA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.79 - $7.98
Previous Close$0.83
Volume63.94K
Average Volume (3M)704.09K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$5.87M
Total Debt (Recent Filing)$108.86K
Price to Earnings (P/E)-1.0
Beta-0.29
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.81
Shares Outstanding14,780,885
10 Day Avg. Volume62,217
30 Day Avg. Volume704,090
Standard Deviation0.51
R-Squared0.39
Alpha-0.25
Financial Highlights & Ratios
Price to Book (P/B)1.64
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
MIRA Pharmaceuticals, Inc. News
PremiumCompany Announcements
MIRA Pharmaceuticals Board Revamp and Strategic Advisory Hire
Ownership Overview
23.95% Insiders
0.06% Mutual Funds
0.19% Other Institutional Investors
75.80% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MIRA FAQ
What was MIRA Pharmaceuticals, Inc.’s price range in the past 12 months?
MIRA Pharmaceuticals, Inc. lowest stock price was $0.79 and its highest was $7.98 in the past 12 months.
What is MIRA Pharmaceuticals, Inc.’s market cap?
Currently, no data Available
When is MIRA Pharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MIRA Pharmaceuticals, Inc.’s earnings last quarter?
Currently, no data Available
Is MIRA Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts MIRA Pharmaceuticals, Inc.’s price is currently Overvalued.
Does MIRA Pharmaceuticals, Inc. pay dividends?
MIRA Pharmaceuticals, Inc. does not currently pay dividends.
What is MIRA Pharmaceuticals, Inc.’s EPS estimate?
MIRA Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MIRA Pharmaceuticals, Inc. have?
MIRA Pharmaceuticals, Inc. has 14,780,885 shares outstanding.
What happened to MIRA Pharmaceuticals, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MIRA Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in MIRA
---
MIRA Pharmaceuticals, Inc. Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland.
---
Technical Analysis
---